Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome associated with high-dose interleukin-2 for the treatment of metastatic melanoma.
暂无分享,去创建一个
[1] S. Swisher,et al. Production of tumor necrosis factor α and interferon γ in interleukin-2-treated melanoma patients: Correlation with clinical toxicity , 2005, Cancer Immunology, Immunotherapy.
[2] F. Giles,et al. Lymphocyte activation and serine-esterase induction following recombinant interleukin-2 infusion for lymphomas and acute leukaemias , 2005, Cancer Immunology, Immunotherapy.
[3] D. Newburg,et al. Escherichia coli Shiga toxin 1 and TNF-alpha induce cytokine release by human cerebral microvascular endothelial cells. , 2004, Microbial pathogenesis.
[4] J. Rand,et al. Controversies in differentiating thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. , 2003, The Mount Sinai journal of medicine, New York.
[5] M. Minden,et al. Vascular Events Associated with Alpha Interferon Therapy , 2003, Leukemia & lymphoma.
[6] G. Choquet-Kastylevsky,et al. Adverse effects of immunotherapeutics involving the immune system. , 2002, Toxicology.
[7] P. Raanani,et al. Immune-Mediated Complications during Interferon Therapy in Hematological Patients , 2002, Acta Haematologica.
[8] T. Pysher,et al. Response to Shiga Toxin-1, with and without Lipopolysaccharide, in a Primate Model of Hemolytic Uremic Syndrome , 2001, American Journal of Nephrology.
[9] J. Lee,et al. Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[10] T. Honda,et al. Increased Serum IL-10 and Endothelin Levels in Hemolytic Uremic Syndrome Caused by Escherichia coli O157 , 2000, Nephron.
[11] B. Dreyfus,et al. Thrombotic Thrombocytopenic Purpura during Interferon Alpha Treatment for Chronic Myelogenous Leukemia , 1999, Acta Haematologica.
[12] H. Kantarjian,et al. Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia , 1999, Cancer.
[13] O. Wagner,et al. Activation of endothelium by immunotherapy with interleukin‐2 in patients with malignant disorders , 1999, British journal of haematology.
[14] T. Michida,et al. Thrombotic thrombocytopenic purpura developed suddenly during interferon treatment for chronic hepatitis C , 1998, Journal of Gastroenterology.
[15] Taylor Jl,et al. The effects of interferon-alpha on the production and action of other cytokines. , 1998 .
[16] Yang Wang,et al. Verotoxin and ricin have novel effects on preproendothelin-1 expression but fail to modify nitric oxide synthase (ecNOS) expression and NO production in vascular endothelium. , 1998, The Journal of clinical investigation.
[17] J. Dutcher,et al. Fulminant metastatic melanoma complicated by a microangiopathic hemolytic anemia. , 1998, Hematopathology and molecular hematology.
[18] M. Ravid,et al. Thrombotic thrombocytopenic purpura complicating chronic myelogenous leukemia treated with interferon-alpha. A report of two successfully treated patients. , 1998, Acta haematologica.
[19] S. Grossberg,et al. The effects of interferon-alpha on the production and action of other cytokines. , 1998, Seminars in oncology.
[20] M. Lee,et al. Thrombotic thrombo-cytopenic purpura associated with histamine H2-receptor antagonist therapy. , 1996, The Western journal of medicine.
[21] J. Baars,et al. The release of interleukin-8 during intravenous bolus treatment with interleukin-2. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] H. Wada,et al. Plasma cytokine levels in thrombotic thrombocytopenic purpura , 1992, American journal of hematology.
[23] S. Swisher,et al. Production of tumor necrosis factor alpha and interferon gamma in interleukin-2-treated melanoma patients: correlation with clinical toxicity. , 1991, Cancer immunology, immunotherapy : CII.
[24] H. Prydz,et al. Cytokine-induced procoagulant activity in monocytes and endothelial cells. Further enhancement by cyclosporine. , 1988, Transplantation.
[25] A. Murgo. Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents. , 1987, Seminars in hematology.
[26] R. Gallo,et al. Selective in vitro growth of T lymphocytes from normal human bone marrows. , 1976, Science.
[27] A. Santoro,et al. [Thrombotic thrombocytopenic purpura due to administration of Ibuprofen]. , 1974, Minerva nefrologica.